Literature DB >> 23983237

Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men.

Mara M Epstein1, Elizabeth Crabb Breen, Larry Magpantay, Roger Detels, Lauren Lepone, Sudhir Penugonda, Jay H Bream, Lisa Paula Jacobson, Otoniel Martínez-Maza, Brenda M Birmann.   

Abstract

BACKGROUND: Prospective cohort studies often quantify serum immune biomarkers at a single time point to determine risk of cancer and other chronic diseases that develop years later. Estimates of the within-person temporal stability of serum markers partly assess the utility of single biomarker measurements and may have important implications for the design of prospective studies of chronic disease risk.
METHODS: Using archived sera collected from 200 HIV-seronegative men at three visits spaced over approximately 2 years, concentrations of 14 biomarkers (ApoA1, sCD14, sgp130, sIL-6R, sIL-2Rα, sTNFR2, BAFF/BLyS, CXCL13, IFN-γ, interleukin [IL]-1β, IL-6, IL-8, IL-10, and TNF-α) were measured in a single laboratory. Age- and ethnicity-adjusted intraclass correlation coefficients (ICC) were calculated for each biomarker, and mixed linear regression models were used to examine the influence of age, ethnicity, season, and study site on biomarker concentrations.
RESULTS: Across all three study visits, most biomarkers had ICC values indicating fair to excellent within-person stability. ApoA1 (ICC = 0.88) and TNF-α (ICC = 0.87) showed the greatest stability; the ICC for IL-8 (ICC = 0.33) was remarkably less stable. The ICCs were similar when calculated between pairs of consecutive visits. The covariables did not influence biomarker levels or their temporal stability. All biomarkers showed moderate to strong pairwise correlations across visits.
CONCLUSIONS: Serum concentrations of most evaluated immune biomarkers displayed acceptable to excellent within-person temporal reliability over a 2-year period. Further investigation may be required to clarify the stability of IL-8. IMPACT: These findings lend support to using these serologic immune biomarkers in prospective studies investigating associations with chronic diseases. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23983237      PMCID: PMC3829469          DOI: 10.1158/1055-9965.EPI-13-0379

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

1.  IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes.

Authors:  Jason C O'Connor; Ansuman Satpathy; Matthew E Hartman; Emily M Horvath; Keith W Kelley; Robert Dantzer; Rodney W Johnson; Gregory G Freund
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

2.  Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women.

Authors:  Gloria Y F Ho; Xiao-Nan Xue; Robert D Burk; Robert C Kaplan; Elaine Cornell; Mary Cushman
Journal:  Cytokine       Date:  2005-04-07       Impact factor: 3.861

3.  Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma.

Authors:  L M Kirstein; J W Mellors; C R Rinaldo; J B Margolick; J V Giorgi; J P Phair; E Dietz; P Gupta; C H Sherlock; R Hogg; J S Montaner; A Muñoz
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

4.  Multisite comparison of high-sensitivity multiplex cytokine assays.

Authors:  Elizabeth Crabb Breen; Sandra M Reynolds; Christopher Cox; Lisa P Jacobson; Larry Magpantay; Candice B Mulder; Oliver Dibben; Joseph B Margolick; Jay H Bream; Elise Sambrano; Otoniel Martínez-Maza; Elizabeth Sinclair; Persephone Borrow; Alan L Landay; Charles R Rinaldo; Philip J Norris
Journal:  Clin Vaccine Immunol       Date:  2011-06-22

Review 5.  Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.

Authors:  A Rabinovitch; W L Suarez-Pinzon
Journal:  Biochem Pharmacol       Date:  1998-04-15       Impact factor: 5.858

6.  Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.

Authors:  Jennifer Rider Stark; Haojie Li; Peter Kraft; Tobias Kurth; Edward L Giovannucci; Meir J Stampfer; Jing Ma; Lorelei A Mucci
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

7.  Plasma prolactin concentrations and risk of postmenopausal breast cancer.

Authors:  Shelley S Tworoger; A Heather Eliassen; Bernard Rosner; Patrick Sluss; Susan E Hankinson
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

8.  Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error.

Authors:  B Rosner; D Spiegelman; W C Willett
Journal:  Am J Epidemiol       Date:  1992-12-01       Impact factor: 4.897

9.  The Multicenter AIDS Cohort Study: retention after 9 1/2 years.

Authors:  J Dudley; S Jin; D Hoover; S Metz; R Thackeray; J Chmiel
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

10.  Temporal reliability of cytokines and growth factors in EDTA plasma.

Authors:  Tess V Clendenen; Alan A Arslan; Anna E Lokshin; Annika Idahl; Göran Hallmans; Karen L Koenig; Adele M Marrangoni; Brian M Nolen; Nina Ohlson; Anne Zeleniuch-Jacquotte; Eva Lundin
Journal:  BMC Res Notes       Date:  2010-11-13
View more
  33 in total

1.  Autoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive heart disease.

Authors:  Xiaoyang Li; Tatiana Kuznetsova; Nicholas Cauwenberghs; Matthew Wheeler; Holden Maecker; Joseph C Wu; Francois Haddad; Hongjie Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

2.  Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Authors:  Britton Trabert; Ligia Pinto; Patricia Hartge; Troy Kemp; Amanda Black; Mark E Sherman; Louise A Brinton; Ruth M Pfeiffer; Meredith S Shiels; Anil K Chaturvedi; Allan Hildesheim; Nicolas Wentzensen
Journal:  Gynecol Oncol       Date:  2014-08-23       Impact factor: 5.482

3.  Emotional acceptance, inflammation, and sickness symptoms across the first two years following breast cancer diagnosis.

Authors:  Rebecca G Reed; Karen L Weihs; David A Sbarra; Elizabeth C Breen; Michael R Irwin; Emily A Butler
Journal:  Brain Behav Immun       Date:  2016-02-23       Impact factor: 7.217

4.  Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitis.

Authors:  John Gubatan; Shuji Mitsuhashi; Maria Serena Longhi; Talia Zenlea; Laura Rosenberg; Simon Robson; Alan C Moss
Journal:  Cytokine       Date:  2018-01-08       Impact factor: 3.861

5.  Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop.

Authors:  Danielle M Carrick; Anil K Chaturvedi; Meredith S Shiels; Rao L Divi; Kelly K Filipski; Elizabeth F Hebert; Mukesh Verma; Allan Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-24       Impact factor: 4.254

6.  The role of the ventral striatum in inflammatory-induced approach toward support figures.

Authors:  Tristen K Inagaki; Keely A Muscatell; Michael R Irwin; Mona Moieni; Janine M Dutcher; Ivana Jevtic; Elizabeth C Breen; Naomi I Eisenberger
Journal:  Brain Behav Immun       Date:  2014-10-16       Impact factor: 7.217

7.  Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Authors:  Britton Trabert; Ronald C Eldridge; Ruth M Pfeiffer; Meredith S Shiels; Troy J Kemp; Chantal Guillemette; Patricia Hartge; Mark E Sherman; Louise A Brinton; Amanda Black; Anil K Chaturvedi; Allan Hildesheim; Sonja I Berndt; Mahboobeh Safaeian; Ligia Pinto; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2016-11-07       Impact factor: 7.396

8.  Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression.

Authors:  Mona Moieni; Michael R Irwin; Ivana Jevtic; Richard Olmstead; Elizabeth C Breen; Naomi I Eisenberger
Journal:  Neuropsychopharmacology       Date:  2015-01-19       Impact factor: 7.853

9.  Multiplex assay reliability and long-term intra-individual variation of serologic inflammatory biomarkers.

Authors:  Heather S McKay; Joseph B Margolick; Otoniel Martínez-Maza; Joseph Lopez; John Phair; Giovanna Rappocciolo; Thomas N Denny; Larry I Magpantay; Lisa P Jacobson; Jay H Bream
Journal:  Cytokine       Date:  2016-12-09       Impact factor: 3.861

10.  Exposure to an inflammatory challenge enhances neural sensitivity to negative and positive social feedback.

Authors:  Keely A Muscatell; Mona Moieni; Tristen K Inagaki; Janine M Dutcher; Ivana Jevtic; Elizabeth C Breen; Michael R Irwin; Naomi I Eisenberger
Journal:  Brain Behav Immun       Date:  2016-03-28       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.